Archives
Bazedoxifene and IL-6/GP130 Cancer Signaling
2026-09-16
Shi and colleagues identify bazedoxifene as a repurposing candidate that may inhibit the IL-6/GP130 signaling axis, linking an established osteoporosis medicine to a cancer-relevant survival pathway. Their review integrates pathway biology, computational drug-repositioning evidence, and preclinical oncology findings while highlighting the experiments needed to establish therapeutic selectivity and clinical relevance.
Abiraterone Acetate in Patient-Derived Spheroids
2026-09-15
Abiraterone acetate is a CYP17 inhibitor whose effects in patient-derived prostate spheroids require more than a viability readout. This guide connects steroidogenesis, exposure control, and orthogonal 3D assay endpoints to improve translational prostate cancer research.
ARCA Cy5 EGFP mRNA: Assay Guide
2026-09-15
ARCA Cy5 EGFP mRNA (5-moUTP) combines covalent Cy5 tracking with EGFP expression for direct analysis of mRNA delivery, localization, and translation in mammalian cells. This 5-methoxyuridine modified mRNA is supplied as a 996-nucleotide, ARCA-capped transcript for fluorescence microscopy, flow cytometry, and controlled transfection workflows.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-14
EZ Cap Cy5 Firefly Luciferase mRNA supports a failure-aware workflow that separates cellular uptake from productive translation. Learn how to apply dual optical readouts to delivery optimization, intracellular trafficking, and translational assay design.
Recombinant Human FGF-19 in Renal Injury Research
2026-09-14
Recombinant Human FGF-19 offers a defined way to examine endocrine metabolic signaling alongside septic kidney-injury phenotypes. This article connects FGF-19 reagent selection with WIP1–p38 MAPK pyroptosis research while separating validated evidence from exploratory assay design.
Cy5-UTP for Fluorescent RNA Labeling
2026-09-13
Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7-mediated in vitro transcription RNA labeling. Its reported 650/670 nm excitation and emission maxima support direct detection of labeled RNA in FISH, dual-color expression arrays, and related assays.
Cefoperazone in Translational Resistance Research
2026-09-12
A mechanistic and strategic guide to using Cefoperazone sodium salt in gram-negative resistance studies, antimicrobial assays, comparative β-lactam research, and biliary tract infection models.
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-11
S Tag Peptide is a soluble 15-amino-acid reagent for designing recombinant fusions that support protein detection, antibody-based capture, and protein solubility improvement. It should be used as part of a validated genetically encoded fusion workflow, not as a standalone ribonuclease, and its solutions are intended for short-term aqueous handling.
TRPV1+ Nerves Suppress Inflammation via Reflex
2026-09-11
Song et al. identify a somato-autonomic reflex in which targeted stimulation of TRPV1+ peripheral sensory nerves at the nape activates brainstem, endocrine, autonomic, and splenic pathways to reduce systemic inflammatory signals. The study combines pharmacological and thermal stimulation, cytokine measurements, genetic validation, and splenic RNA sequencing, providing a circuit-level framework for neuroimmune inflammation research.
Cy5.5 NHS ester: Reliable Labeling
2026-09-10
This scenario-driven guide explains how Cy5.5 NHS ester (non-sulfonated), SKU A8103, can support reproducible biomolecule tracking alongside cell viability, proliferation, and cytotoxicity assays. It covers amine-reactive labeling, solvent handling, near-infrared readout, controls, interpretation, and practical vendor selection.
NF 340 and P2Y11: Proving Invasion Pathways
2026-09-10
NF 340 is a P2Y11 antagonist for dissecting purinergic control of breast cancer invasion. This article explains how to use receptor-level pharmacology alongside QPRT, Rho/ROCK, PLC, and myosin-light-chain evidence without overstating causality.
ASB3–MAVS Signaling: From Mechanism to Translation
2026-09-09
The ASB3–MAVS axis illustrates how ubiquitin-dependent protein turnover can reshape antiviral signaling and how carefully designed fluorescence assays can make that mechanism measurable. This thought-leadership guide connects the reference findings to translational workflows using a Cy5 conjugated secondary antibody while distinguishing evidence from practical assay recommendations.
Deracoxib in Canine Mammary Tumor Cells
2026-09-09
The reference study shows that Deracoxib, alone and particularly in combination with piroxicam, reduces viability and promotes apoptosis in the CMT-U27 canine mammary carcinoma cell line. Its principal contribution is a cell-based demonstration that combined cyclooxygenase inhibition can produce stronger antiproliferative effects and G0/G1 accumulation than either drug alone.
Cy5 amine (non-sulfonated): Workflow Guide
2026-09-08
Cy5 amine (non-sulfonated) is an amino-functionalized cyanine dye for covalent labeling when an organic co-solvent can be used during conjugation. It supports fluorescence microscopy, flow cytometry, and molecular tracking workflows, but its water insolubility makes it unsuitable for direct aqueous dissolution and it is not intended for diagnostic or medical use.
BIIE 0246: Mapping NPY Signaling to Translation
2026-09-08
BIIE 0246 offers translational researchers a selective way to interrogate neuropeptide Y Y2 receptor biology across synaptic, gastrointestinal, feeding, and behavioral models. This article connects its established pharmacology with the adipose-neural axis described in recent cardiac arrhythmia research while clearly separating evidence for Y2R from findings centered on Y1R.
3774 records 8/252 page Previous Next First page 上5页 678910 下5页 Last page